MAMarina V. Antonyuk

Marina V. Antonyuk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marina V. Antonyuk has a total of 100 co-authors. Here are the top co-authors by number of shared publications:

  • Tatyana P. Novgorodtseva

    Vladivostok Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Research Institute of Medical Climatology and Rehabilitative Treatment

    40 shared publications
  • Tatyana A. Gvozdenko

    Vladivostok Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Research Institute of Medical Climatology and Rehabilitative Treatment

    39 shared publications
  • Oksana Yu. Kytikova

    Vladivostok Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Research Institute of Medical Climatology and Rehabilitative Treatment

    28 shared publications
  • Yuliya K. Denisenko

    Vladivostok Branch of Far Eastern Scientific Center of Physiology and Pathology of Respiration – Research Institute of Medical Climatology and Rehabilitative Treatment

    23 shared publications
  • Elena Evgenievna Mineeva

    Vladivostok Branch of the Far Eastern Scientific Centre of Physiology and Pathology of Respiration, Scientific Research Institute of Medical Climatology and Rehabilitation Treatment

    12 shared publications
  • Alla V. Yurenko

    Vladivostok Branch of Far Eastern Scientific Centre of Physiology and Pathology of Respiration - Research Institute of Medical Climatology and Rehabilitation Treatment

    11 shared publications

Latest Publications

  • Open Access

    Neurotrophins as a Link Between Cells Involved in the Pathogenesis of Asthma

    by O. Yu. Kytikova, M. V. Antonyuk, V. V. Knyshova, T. P. Novgorodtseva, T. A. Gvozdenko, О. Ю. Кытикова, М. В. Антонюк, В. В. Кнышова, Т. П. Новгородцева, Т. А. Гвозденко

    Currently, research into the pathogenesis of bronchial asthma focuses primarily on immune inflammation and airway remodeling. Both the immune and nervous systems are involved in the development of airway inflammation. Neurotrophic factors, particularly neurotrophins, are expressed by both neuronal and non-neuronal cells. In the lungs, neuro trophins are expressed by epithelial cells, alveolar and interstitial macrophages, eosinophils, and lymphocytes. Disruption of the relationship between nerve, epithelial, and immune cells in the lungs may play a significant role in the pathophysiological changes associated with bronchi al asthma. Aim . The aim of this study is to systematize current knowledge about the neuroimmune mechanisms of bronchial asthma and the role of neurotrophins in mediating the interactions between immune, epithelial cells, and neurons involved in the development of bronchi al hyperreactivity, eosinophilic inflammation, and airway remodeling. Materials and Methods . A narrative literature review was per formed, encompassing 97 publications from 2016 to 2025, to examine the interactions between neurotrophins, immune cells, epithelial cells, and neurons in asthma. Results . Both allergic and non-allergic asthma share an identical inflammatory response mechanism, which is driven by the production of leukocyte-derived, epithelial-derived, and neuro genic mediators and ultimately leads to airway remodelling. The paper discusses the interplay between airway immune inflammation and nervous system activity in a feedback-loop manner. On the one hand, parasympathetic, sympathetic, and sensory neurons act via ILC2-expressed receptors to induce contraction or relaxation of bronchial smooth muscle cells and to trigger or suppress Th2-type inflammation. On the oth er hand, mediators secreted by immune cells stimulate neurons to produce neurotrophins and neuropeptides. Cell survival capacity depends on the number and profile of receptors for neurotrophic factors. The article outlines the currently known pathways of neurotrophin interactions with the nervous and immune systems. Conclusion . The need for further research to elucidate the possibility of regulating neuroimmune disorders is substantiated.

  • Open Access

    The association of metabolic dysregulation with neuroimmune airway inflammation in asthma

    by O. Yu. Kytikova, T. P. Novgorodtseva, M. V. Antonyuk, V. V. Knyshova, T. A. Gvozdenko, О. Ю. Кытикова, Т. П. Новгородцева, М. В. Антонюк, В. В. Кнышова, Т. А. Гвозденко

    Neuroimmune mechanisms and their role in the pathogenesis of asthma have been actively discussed in the scientific literature in recent years. There is emerging evidence of a relationship between neurotrophic factors and lipid metabolism in asthma. Despite the significance of existing research, the literature is insufficient to support a neuro-immune-lipid model of asthma that defines the pathogenetic relationship between these three systems. Brain-derived neurotrophic factor (BDNF) is implicated in the pathogenesis of bronchial hyperreactivity and remodeling, integrating the neuroimmune mechanisms of asthma pathogenesis. Lipid metabolism disturbances in asthma, including an imbalance of proinflammatory and anti-inflammatory lipid mediators, as well as changes in sphingolipid and cholesterol levels in cell membranes, can influence the expression of BDNF and its receptor, which form the BDNF/TrkB signaling pathway. This allows us to consider the relationship between lipids and neurotrophins as a mechanism linking metabolic dysregulation with neuroimmune inflammation and airway remodeling in asthma. In this mechanism, lipids are considered to act as mediators modulating BDNF activity by activating signaling pathways that regulate BDNF gene transcription. Further research will help substantiate a unified neuro-immune-lipid model of asthma pathogenesis.

  • Airway remodeling in bronchial asthma: pathogenetic aspects and diagnostic difficulties

    by E. E. Mineeva, M. V. Antonyuk, T. A. Gvozdenko

    The main reason for the severe and difficult to correct course of asthma is the remodeling of the respiratory tract. The purpose of the review is to summarize the main pathogenetic mechanisms of airway remodeling in asthma and to present the diagnostic capabilities of various methods. Results. The main patterns of development and progression of morphofunctional restructuring of the respiratory tract in asthma are presented. The involvement of immune cells and the role of angiogenesis in the remodeling of the respiratory tract are shown. Instrumental and laboratory diagnostic methods are considered. The diagnosis of airway remodeling faces a number of difficulties. Currently, there are no available non-invasive methods for assessing airway remodeling with high sensitivity and specificity. The lack of informative biomarkers available for airway remodeling limits clinical studies of this process. Understanding the pathogenetic mechanisms, timely diagnosis and treatment of airway remodeling is a promising strategy for preventing the onset and progression of asthma. Conclusion. The pathogenetic mechanisms and modern diagnostic methods of airway remodeling in asthma described and systematized in the review are intended to help in the search for new therapeutic targets for the prediction and treatment of the disease.

  • Transient receptor potential ankyrin channel and brain-derived neurotrophic factor in the pathogenesis of asthma: ways of interaction

    by O. Yu. Kytikova, T. P. Novgorodtseva, M. V. Antonyuk, T. A. Gvozdenko

    The complexity of the pathogenesis of bronchial asthma (BA) has been caused by the influence of the environmental, genetic and epigenetic factors that interact with each other and contribute to the development and exacerbation of this pathology. In recent years researchers have focused on the neurogenic component of the BA pathogenesis. The ankyrin receptor TRPA1(the transient receptor potential cation channel subfamily A member 1) is expressed in the sensory C-fibers of the lungs and activated by the cold, cigarette smoke, allergens and number of chemicals that are the triggers of BA. It triggers the influx of Ca 2+ into sensory neurons and activates the cascades responsible for the expression of the brain-derived neurotrophic factor (BDNF) gene. BDNF is involved in airway remodeling, enhances airway innervation and exacerbates airway hyperreactivity, and also maintains sensory hypersensitivity through a feedback loop. BDNF gene polymorphisms confer susceptibility to BA, with carriers of TRPA1 gene polymorphisms more sensitive to epigenetic modifications and may have strong BDNF expression in response to the stimuli. Despite the fact that the epigenetics of TRPA1 and BDNF in BA is under study, the epigenetic changes of TRPA1 and BDNF are well described in neurology, which may be interesting in the context of their interaction in BA, given the role of neuroimmune inflammation in the pathogenesis of this disease. The present review discusses the role and relationship of genetic and epigenetic changes induced by environmental factors initiating BA development, as well as role of TRPA1 and BDNF in this process.

  • Open Access

    The role of brain-derived neurotrophic factors in the pathogenesis of asthma in elderly

    by O. Yu. Kytikova, M. V. Antonyuk, T. P. Novgorodtseva, T. A. Gvozdenko, A. A. Uksumenko, K. A. Syunikova

    The brain-derived neurotrophic factor (BDNF) is abundantly expressed in nervous and immune systems, as well as in bronchopulmonary system and involves in cellular aging, which figures out interest in studying its role in asthma pathogenesis in the elderly (late asthma). BDNF activation can occur not only through its connection with cellular receptors (tropomyosin receptor kinase B (TrkB) and P75 neurotrophic receptor (p75NTR), but also through Keap1/ Nrf2 pathway. Both signalling pathways linked with asthma and aging. In addition, Keap1-independent pathways of Nrf2 activation were described, which are associated with the activity of BDNF and also participate in the aging process and pathogenesis of the asthma. Aging cells acquire senescence-associated secretory phenotype (SASP), which is involved in the progression of immunosenescence, inflammaging, lung aging and is capable of mediating the development of asthma in elderly. On the other hand, aging cells can express BDNF and TRKB, which support their viability through SASP. The fact that TRK inhibitors can reduce the viability of aging cells in the experiment allows us to look in a new way at the role of TRKB/BDNF as a target in the treatment of asthma. The role of Nrf2 is described in cellular aging and related SASP, which can also be of interest from the standpoint of studying its role in pathogenesis in the elderly. This review summarizes modern information regarding BDNF, its receptor and receptor-dependent action, as well as the role in inflammation, inflammaging and asthma pathogenesis in elderly.

  • Open Access

    Mediators and signaling pathways in myocardial fibrosis

    by O. Yu. Kytikova, M. V. Antonyuk, T. P. Novgorodtseva, T. A. Gvozdenko

    Myocardial fibrosis is closely associated with severe cardiovascular diseases, characterized by increased mortality rates worldwide. The development of myocardial fibrosis is based on the differentiation of fibroblasts into myofibroblasts, which synthesize components of the extracellular matrix in excess. A key regulator of fibroblast differentiation into myofibroblasts is transforming growth factor-beta. In recent years, close attention in the pathogenesis of fibrosis has been given to other growth factors – neurotrophins. It was recently discovered that fibroblasts express brain-derived neurotrophic factor (BDNF), and its receptors are involved in the pathogenesis of fibrosis of various organs and tissues. The role of BDNF and its receptors in the pathogenesis of myocardial fibrosis is just beginning to be studied. This review summarizes the information available in the literature (2019-2023) on the pathophysiological and pathogenetic mechanisms of the relationship between BDNF and cardiac fibrosis. Data presented in the literature showed that the mechanisms of action of BDNF in the cardiovascular system and the pathogenesis of cardiac fibrosis have common points of intersection, which makes this neurotrophin a promising therapeutic target for cardiac fibrosis. Further investigation of these aspects will allow the use of various external effects of BDNF to develop technology for the prevention of cardiac fibrosis.

  • Open Access

    On the diagnosis of smallairway dysfunction in mild asthma

    by А. V. Yurenko, М. V. Аntonyuk, Е. Е. Мineeva

    Aim. To assess the functional status of the small airways by bodyplethysmography and to determine the degree of small-airway dysfunction (SAD) in patients with mild asthma.Materials and methods. We examined 191 patients with mild asthma. The control group consisted of 36 healthy volunteers. Using bodyplethysmography, we evaluated functional residual capacity (FRC), residual volume (RV), total lung capacity (TLC) and the RV/TLC ratio. SAD was defined as RV > 140% predicted, RV/TLC > 125% predicted or FRC > 130% predicted. The severity of SAD was graded by percentage deviation from predicted values and z-scores.Results. SAD was detected in 44 asthma patients. Cluster analysis based on RV, RV/TLC and FRC divided these patients into three clusters. Statistically significant differences between clusters were found for RV, RV/TLC and their z-scores. Cluster 1 was characterised by elevated RV and RV/TLC. In Cluster 2, compared with Cluster 1, high RV and RV/TLC were accompanied by an FRC increase in 50% of cases. Cluster 3 showed high RV, RV/TLC and FRC, along with a TLC increase in 55% of cases. Spirometry demonstrated a progressive decline in airway patency, reflected by reduced FEV1 and maximum expiratory flow rates (MEF); worsening obstruction resulted in reduced VC in Clusters 2 and 3. SAD was consistently accompanied by elevated RV and RV/TLC, indicating marked air-trapping.Conclusion. SAD occurred in 23% of patients with mild asthma and was accompanied by a pronounced decrease in indices characteristic of bronchial-obstructive syndrome, including distal airways. RV, RV/TLC and their z-scores constitute the primary criteria for grading SAD in this patient population.

  • Сomplex rehabilitation treatment of patients with stage III discirculatory encephalopathy

    by Elena V. Moroz, Marina V. Antonyuk, Vera V. Knyshova, Vladimir N. Potapov

    BACKGROUND: The main task in the treatment of stage III dyscirculatory encephalopathy is to prevent the rapid progression of cognitive impairment and improve the quality of life of patients. It is assumed that the integrated use of non-drug and drug treatment methods makes it possible to correct impaired neuropsychological functions in this category of patients. OBJECTIVE: To evaluate the integrated use of cognitive training and low-frequency pulsed magnetic therapy to optimize the rehabilitation treatment of patients with stageIII dyscirculatory encephalopathy. MATERIAL AND METHODS: An open prospective comparative study was conducted in which 185patients aged 60–85years with a diagnosis of stageIII discirculatory encephalopathy took part. Group1 (n=60) included patients who received drug therapy and cognitive training, group2 (n=64)— drug therapy, cognitive training and low-frequency pulsed magnetic therapy; group3 (n=61)— only medications. The course of treatment was 3months. The effectiveness of rehabilitation treatment was assessed by changes in neurological status, short-term and long-term memory tests (10-word test), attention (correction test), functional independence in everyday life, and rehabilitation potential. Long-term results were assessed 3 months after completion of the course of treatment. RESULTS: After the course of treatment, patients in group1 demonstrated an increase in short-term and long-term memory by 83% (p0.05) and 65.8% (p0.05), a decrease in the number of errors in the proofreading test by 11% (p0.05), neurological disorders by 13% (p0.05), and an increase in RP to a high level in 35% of patients. The effects were leveled out three months after the course of treatment. In group2, short-term and long-term memory increased by 82% (p0.05) and 66% (p0.05), attention by 36% (p0.05), neurological disorders decreased by 19% (p0.05), functional independence of patients according to the IADL scale increased by 27% (p0.05) and RP to a high level in 70.3% of patients. The therapeutic effects persisted for three months after the course of treatment. The most effective was the complex with cognitive training and low-frequency pulsed magnetic therapy (2nd group).

  • Open Access

    Laser therapy capabilities using Multiwave Locked System in pulmonology

    by N. S. Yubitskaya, M. V. Antonyuk, N. D. Rozhkova

    Introduction. Laser therapy is a pathogenetically justified method for treating diseases of the bronchopulmonary system. With the advent of the Multiwave Locked System (MLS therapy), which combines continuous (808 nm) and pulsed (905 nm) emission modes, the possibilities of laser therapy for bronchopulmonary diseases have expanded. The aim of this review is to present the capabilities of laser therapy using the Multiwave Locked System (MLS therapy) in pulmonology. Materials and methods. A literature search was conducted in the PubMed/MedLine and eLIBRARY databases for the period from 2010 to 2024. Results. The analysis of literature data showed that the use of MLS therapy in bronchopulmonary diseases is a justified and effective treatment method. The use of MLS therapy in the comprehensive medical rehabilitation of pulmonary patients not only provides pronounced anti-inflammatory, anti-edematous, analgesic, and immunomodulating effects, but also improves lung function, peripheral oxygen saturation, increases exercise tolerance, and prevents the development of fibrosis.

  • Open Access

    Brain-derived neurotrophic factor in the pathogenesis of comorbid coronary artery disease and depression: a review

    by O. Yu. Kytikova, M. V. Antonyuk, T. P. Novgorodtseva, T. A. Gvozdenko

    Coronary artery disease (CAD) and depression are characterized by high bilateral comorbidity, but its pathogenesis is practically not studied.In the last decade, neurogenic mechanisms of the inflammatory response and brain-derived neurotrophic factor (BDNF), which can explain the relationship between depression and CAD, have been studied. The review summarizes the available information on BDNF role in the pathogenesis of CAD and depression, as well as their comorbid course for the period of 2019-2024. Based on the literature review, we identified the components and systems that are most promising for studying the BDNF role in the pathogenesis of these multifactorial diseases (genetics, inflammation, neuroinflammation, endothelial dysfunction and platelet hyperactivation, hypothalamic-pituitary-adrenal system, low-density lipoproteins and triglycerides). The review emphasizes the important role of BDNF in the development of depression in CAD and the need for further research in this area.